Nf1 deficiency causes Ras-Dediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

Neurofibromatosis, Phenotype, Natural History, and Pathogenesis

Riccardi, V. M., & Smirniotopoulos, J. G. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199211000-00009 · Cited by 789 · see citing works

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., & Weinberg, R. A. (1994) · Nature Genetics · doi:10.1038/ng0794-353 · Cited by 780 · see citing works

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 669 · see citing works

BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein

Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80094-7 · Cited by 657 · see citing works

Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Nordlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., & Copeland, N. G. (1994) · Genes & Development · doi:10.1101/gad.8.9.1019 · Cited by 641 · see citing works

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C., & Lowy, D. R. (1992) · Cell · doi:10.1016/0092-8674(92)90407-4 · Cited by 580 · see citing works

Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells

Hestdal, K., Ruscetti, F. W., Ihle, J. N., Jacobsen, S. E. W., Dubois, C. M., Kopp, W. C., Longo, D., & Keller, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.22 · Cited by 464 · see citing works

Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid Disorders

Shannon, K., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P. A., & McCormick, F. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300903 · Cited by 440 · see citing works

Bcr‐Abl oncoproteins bind directly to activators of the Ras signalling pathway.

Puil, L. J., Liu, J., Gish, G., Mbamalu, G., Bowtell, D. D. L., Pelicci, P. G., Arlinghaus, R. B., & Pawson, T. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438 · see citing works

Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5

Miyajima, A., Mui, A. L.-F., Ogorochi, T., & Sakamaki, K. (1993) · Blood · doi:10.1182/blood.v82.7.1960.bloodjournal8271960 · Cited by 414 · see citing works

Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage

Lang, R. A., Metcalf, D., Cuthbertson, R. A., Lyons, I. G., Stanley, E. G., Kelso, A., Kannourakis, G., Williamson, D. J., Klintworth, G. K., Gonda, T. J., et al. (1987) · Cell · doi:10.1016/0092-8674(87)90136-x · Cited by 366 · see citing works

Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors

Emanuel, P., Bates, L. J., Castleberry, R., Gualtieri, R., & Zuckerman, K. (1991) · Blood · doi:10.1182/blood.v77.5.925.925 · Cited by 336 · see citing works

Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4.

Satoh, T., Nakafuku, M., Miyajima, A., & Kaziro, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3314 · Cited by 329 · see citing works

Neurofibromatosis and childhood leukemia

Bader, J. L., & Miller, R. W. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80362-x · Cited by 269 · see citing works

Malignancy in Neurofibromatosis

S�rensen, S. A., Mulvihill, J. J., & Nielsen, A. (2015) · Familial Cancer · doi:10.1159/000412547 · Cited by 269 · see citing works

ras oncogenes: their role in neoplasia

Barbacid, M. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01848.x · Cited by 242 · see citing works

Neurofibromatosis, Phenotype, Natural History, and Pathogenesis

Riccardi, V. M., & Smirniotopoulos, J. G. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199211000-00010 · Cited by 233 · see citing works

RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.

Janssen, J. W. G., Steenvoorden, A. C. M., Lyons, J., Anger, B., Böhlke, J. U., Bos, J. L., SELIGER, H., & Bartram, C. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9228 · Cited by 225 · see citing works

A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte‐macrophage colony stimulating factor.

Johnson, G. R., Gonda, T. J., Metcalf, D., Hariharan, I. K., & Cory, S. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03396.x · Cited by 180 · see citing works

The neurofibromatosis type 1 gene and its protein product, neurofibromin

Gutmann, D. H., & Collins, F. S. (1993) · Neuron · doi:10.1016/0896-6273(93)90324-k · Cited by 168 · see citing works

Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras

Kalra, R., Paderanga, D., Olson, K., & Shannon, K. (1994) · Blood · doi:10.1182/blood.v84.10.3435.3435 · Cited by 162 · see citing works

Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

Sogani, P. C., Vagaiwala, M. R., & Whitmore, W. F. (1984) · Cancer · doi:10.1002/1097-0142(1984)54:4 · Cited by 160 · see citing works

Neurofibromatosis type 1 gene mutations in neuroblastoma

The, I., Murthy, A. E., Hannigan, G. E., Jacoby, L. B., Menon, A. G., Gusella, J. F., & Bernards, A. (1993) · Nature Genetics · doi:10.1038/ng0193-62 · Cited by 155 · see citing works

Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP.Ras.

Johnson, M. R., Look, A. T., DeClue, J. E., Valentine, M. B., & Lowy, D. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5539 · Cited by 140 · see citing works

Neurofibromatosis and Cancer

Bader, J. L. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb48062.x · Cited by 110 · see citing works

Tumurigenesis by slow-transforming retroviruses—an update

van Lohuizen, M., & Berns, A. J. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90005-l · Cited by 106 · see citing works

Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function

Johnson, M. R., DeClue, J. E., Felzmann, S., Vass, W. C., Xu, G., White, R. L., & Lowy, D. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.641 · Cited by 102 · see citing works

Evi-2, a Common Integration Site Involved in Murine Myeloid Leukemogenesis

Buchberg, A. M., Bedigian, H. G., Jenkins, N. A., & Copeland, N. G. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4658 · Cited by 93 · see citing works

Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice

Jenkins, N. A., Copeland, N. G., Taylor, B. A., Bedigian, H. G., & Lee, B. K. (1982) · Journal of Virology · doi:10.1128/jvi.42.2.379-388.1982 · Cited by 82 · see citing works

Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice

Bedigian, H. G., Johnson, D. A., Jenkins, N. A., Copeland, N. G., & Evans, R. (1984) · Journal of Virology · doi:10.1128/jvi.51.3.586-594.1984 · Cited by 71 · see citing works

Oncogenes at viral integration sites.

Peters, G. B. (1990) · PubMed · Cited by 65 · see citing works

Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels

Largaespada, D. A., Shaughnessy, J. D., Jenkins, N. A., & Copeland, N. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.5095-5102.1995 · Cited by 64 · see citing works

Density distribution analysis of In vivo and In vitro colony forming cells in developing fetal liver

Moore, M. A. S., McNeill, T. A., & Haskill, J. S. (1970) · Journal of Cellular Physiology · doi:10.1002/jcp.1040750207 · Cited by 59 · see citing works

Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by myb

Gonda, T., Macmillan, E. M., Townsend, P., & Hapel, A. (1993) · Blood · doi:10.1182/blood.v82.9.2813.2813 · Cited by 27 · see citing works

Transcription Factors, Normal Myeloid Development, and Leukemia

Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · see citing works

Germline KRAS mutations cause Noonan syndrome

Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730 · see citing works

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

Loh, M. L. (2003) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 422 · see citing works

Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Niemeyer, C. M., Aricò, M., Basso, G., Biondi, A., Rajnoldi, A. C., Creutzig, U., Haas, O. A., Harbott, J., Hasle, H., Kerndrup, G. B., et al. (1997) · PubMed · doi:10.1182/blood.v89.10.3534 · Cited by 405 · see citing works

The tyrosine phosphatase Shp2 (PTPN11) in cancer

Chan, G., Kalaitzidis, D., & Neel, B. G. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9126-y · Cited by 383 · see citing works

PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase

Chan, R. J., & Feng, G. (2006) · Blood · doi:10.1182/blood-2006-07-028829 · Cited by 378 · see citing works

Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5

Roberts, C. W. M., Leroux, M. M., Fleming, M. D., & Orkin, S. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00185-x · Cited by 333 · see citing works

THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS

Gibbs, W. W., & Oliff, A. I. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.143 · Cited by 324 · see citing works

Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias

Nakamura, T., Largaespada, D. A., Shaughnessy, J. D., Jenkins, N. A., & Copeland, N. G. (1996) · Nature Genetics · doi:10.1038/ng0296-149 · Cited by 303 · see citing works

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Reuter, C. W., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300 · see citing works

Somatic activation of oncogenic <i>Kras</i> in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder

Braun, B. S., Tuveson, D. A., Kong, N., Le, D. T., Kogan, S. C., Rozmus, J., Le Beau, M. M., Jacks, T. E., & Shannon, K. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307203101 · Cited by 299 · see citing works

Homozygous Inactivation of theNF1Gene in Bone Marrow Cells from Children with Neurofibromatosis Type 1 and Malignant Myeloid Disorders

Side, L. E., Taylor, B. R., Cayouette, M. C., Conner, E. R., Thompson, P., Luce, M. C., & Shannon, K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362404 · Cited by 294 · see citing works

The role of Shp2 (PTPN11) in cancer

Mohi, G., & Neel, B. G. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.011 · Cited by 277 · see citing works

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations

Mohi, G., Williams, I. R., Dearolf, C. R., Chan, G., Kutok, J. L., Cohen, S. L., Morgan, K. J., Boulton, C. L., Shigematsu, H., Keilhack, H., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.010 · Cited by 274 · see citing works

Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease

Chan, I. T., Kutok, J. L., Williams, I. R., Cohen, S., Kelly, L., Shigematsu, H., Johnson, L., Akashi, K., Tuveson, D. A., Jacks, T., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20476 · Cited by 270 · see citing works

Juvenile Myelomonocytic Leukemia

Aricò, M., Biondi, A., & Pui, C. (1997) · Blood · doi:10.1182/blood.v90.2.479 · Cited by 250 · see citing works

Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage

Passegue, E. A., Jochum, W., Schorpp‐Kistner, M., Möhle-Steinlein, U., & Wagner, E. F. (2001) · Cell · doi:10.1016/s0092-8674(01)00188-x · Cited by 236 · see citing works

Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.

Beau, M. M. L., Espinosa, R., Davis, E. M., Eisenbart, J. D., Larson, R. A., & Green, E. D. (1996) · PubMed · doi:10.1182/blood.v88.6.1930.bloodjournal8861930 · Cited by 232 · see citing works

Neurofibromatosis type 1 (NF1)

Ferner, R. E., & Gutmann, D. H. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00053-9 · Cited by 230 · see citing works

GTPase activating proteins: critical regulators of intracellular signaling

Donovan, S., Shannon, K., & Bollag, G. E. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00041-5 · Cited by 215 · see citing works

Targeting oncogenic Ras signaling in hematologic malignancies

Ward, A. F., Braun, B. S., & Shannon, K. (2012) · Blood · doi:10.1182/blood-2012-05-378596 · Cited by 207 · see citing works

Mutations of the NF1 Gene in Children With Juvenile Myelomonocytic Leukemia Without Clinical Evidence of Neurofibromatosis, Type 1

Side, L. E., Emanuel, P. D., Taylor, B. R., Franklin, J. L., Thompson, P., Castleberry, R. P., & Shannon, K. (1998) · Blood · doi:10.1182/blood.v92.1.267.413a31_267_272 · Cited by 206 · see citing works

Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1

Costa, R. M., Yang, T., Huynh, D. P., Pulst, S. M., Viskochil, D. H., Silva, A. J., & Brannan, C. I. (2001) · Nature Genetics · doi:10.1038/86898 · Cited by 198 · see citing works

RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

Flotho, C., Valcamonica, S., Mach‐Pascual, S., Schmahl, G. E., Corral, L., Ritterbach, J., Hasle, H., Aricò, M., Biondi, A., & Niemeyer, C. M. (1999) · Leukemia · doi:10.1038/sj.leu.2401240 · Cited by 194 · see citing works

RASand Leukemia: From Basic Mechanisms to Gene-Directed Therapy

Beaupre, D. M., & Kurzrock, R. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1071 · Cited by 192 · see citing works

Ras proteins in the control of the cell cycle and cell differentiation

Crespo, P., & León, J. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000645 · Cited by 189 · see citing works

Rap1 GTPase: Functions, Regulation, and Malignancy

Hattori, M. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg180 · Cited by 184 · see citing works

Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart

Lakkis, M. M., & Epstein, J. A. (1998) · Development · doi:10.1242/dev.125.22.4359 · Cited by 183 · see citing works

Genetic and Biochemical Evidence That Haploinsufficiency of the Nf1 Tumor Suppressor Gene Modulates Melanocyte and Mast Cell Fates in Vivo

Ingram, D. A., Yang, F., Travers, J. B., Wenning, M. J., Hiatt, K. K., New, S., Hood, A. F., Shannon, K., Williams, D. A., & Clapp, D. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.181 · Cited by 181 · see citing works

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder

Le, D., Kong, N., Zhu, Y., Lauchle, J., Aiyigari, A., Braun, B. S., Wang, E., Kogan, S. C., Beau, M. M. L., Parada, L. F., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2650 · Cited by 175 · see citing works

Identification of NF1 mutations in both alleles of a dermal neurofibroma

Sawada, S., Florell, S. R., Purandare, S. M., Ota, M., Stephens, K. G., & Viskochil, D. H. (1996) · Nature Genetics · doi:10.1038/ng0996-110 · Cited by 173 · see citing works

Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1

Klose, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1261 · Cited by 161 · see citing works

Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia

Loh, M. L. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08525.x · Cited by 159 · see citing works

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

Blalock, W. L., Oppenheimer, C. W., Chang, F., Hoyle, P., Wang, X. Y., Algate, P. A., Franklin, R. A., Oberhaus, S. M., Steelman, L. S., & McCubrey, J. A. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 158 · see citing works

Juvenile myelomonocytic leukemia: who’s the driver at the wheel?

Niemeyer, C. M., & Flotho, C. (2019) · Blood · doi:10.1182/blood-2018-11-844688 · Cited by 157 · see citing works

Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor

Chan, R. J., Leedy, M. B., Munugalavadla, V., Voorhorst, C. S., Li, Y., Yu, M., & Kapur, R. (2005) · Blood · doi:10.1182/blood-2004-10-4002 · Cited by 156 · see citing works

Juvenile myelomonocytic leukemia: A report from the 2nd International JMML Symposium

Chan, R. J., Cooper, T. M., Kratz, C. P., Weiss, B., & Loh, M. L. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.08.022 · Cited by 155 · see citing works

<i>Nf1</i> Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines

Zhang, Y.-Y., Vik, T. A., Ryder, J. W., Srour, E. F., Jacks, T., Shannon, K., & Wade Clapp, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.11.1893 · Cited by 150 · see citing works

Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells

Schubbert, S., Lieuw, K. H., Rowe, S. L., Lee, C. M., Li, X., Loh, M. L., Clapp, D. W., & Shannon, K. (2005) · Blood · doi:10.1182/blood-2004-11-4207 · Cited by 148 · see citing works

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options

Niemeyer, C. M., & Kratz, C. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06958.x · Cited by 147 · see citing works

Neurofibromatosis

McClatchey, A. I. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091940 · Cited by 142 · see citing works

Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis

Woodruff, J. M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990326)89:1 · Cited by 229 · see citing works

Nf1-Deficient Mouse Schwann Cells Are Angiogenic and Invasive and Can Be Induced To Hyperproliferate: Reversion of Some Phenotypes by an Inhibitor of Farnesyl Protein Transferase

Kim, H. A., Ling, B., & Ratner, N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.862 · Cited by 140 · see citing works

Ras Proteins: Recent Advances and New Functions

Rebollo, A., & Martínez‐A, C. (1999) · Blood · doi:10.1182/blood.v94.9.2971 · Cited by 140 · see citing works

Nf1 and Gmcsf Interact in Myeloid Leukemogenesis

Birnbaum, R. A., O'Marcaigh, A. S., Wardak, Z., Zhang, Y., Dranoff, G., Jacks, T., Clapp, D. W., & Shannon, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80415-3 · Cited by 138 · see citing works

Single Cell Ras-GTP Analysis Reveals Altered Ras Activity in a Subpopulation of Neurofibroma Schwann Cells but Not Fibroblasts

Sherman, L. S., Atit, R. P., Rosenbaum, T., Cox, A. D., & Ratner, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001702200 · Cited by 135 · see citing works

Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1–haploinsufficient osteoclast functions

Yang, F., Shi, C., Robling, A. G., Yu, X., Nebesio, T. D., Yan, J., Morgan, T., Li, X., Yuan, J., Hock, J. M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29092 · Cited by 134 · see citing works

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice

Ishida, D., Kometani, K., Yang, H., Kakugawa, K., Masuda, K., Iwaï, K., Suzuki, M., Itohara, S., Nakahata, T., Hiai, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00163-6 · Cited by 133 · see citing works

Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation

Gutmann, D. H., Loehr, A., Zhang, Y., Kim, J., Henkemeyer, M. J., & Cashen, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202829 · Cited by 133 · see citing works

Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis

Dai, C., Santagata, S., Tang, Z., Shi, J., Cao, J., Kwon, H., Bronson, R. T., Whitesell, L. J., & Lindquist, S. L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62727 · Cited by 131 · see citing works

Cell-cycle–dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling

Morgan, M. A., Dolp, O., & Reuter, C. W. (2001) · Blood · doi:10.1182/blood.v97.6.1823 · Cited by 128 · see citing works

Cerebrospinal Fluid Proteomic Analysis Reveals Dysregulation of Methionine Aminopeptidase-2 Expression in Human and Mouse Neurofibromatosis 1–Associated Glioma

Dasgupta, B., Yi, Y., Hegedűs, B., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1842 · Cited by 128 · see citing works

Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia

Emanuel, P. D. (2008) · Leukemia · doi:10.1038/leu.2008.162 · Cited by 127 · see citing works

Neurofibromin GTPase-activating Protein-related Domains Restore Normal Growth in Nf1−/− Cells

Hiatt, K. K., Ingram, D. A., Zhang, Y., Bollag, G. E., & Clapp, D. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009202200 · Cited by 126 · see citing works

Neurofibromin Regulates Neural Stem Cell Proliferation, Survival, and Astroglial Differentiation In Vitro and In Vivo

Dasgupta, B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4693-04.2005 · Cited by 125 · see citing works

Mast cells and the neurofibroma microenvironment

Staser, K. W., Yang, F., & Clapp, D. W. (2010) · Blood · doi:10.1182/blood-2009-09-242875 · Cited by 121 · see citing works

The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis

Tefferi, A., & Gilliland, D. G. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.7.947 · Cited by 119 · see citing works

Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia

Axelrad, A. A., Eskinazi, D., Correa, P. N., & Amato, D. (2000) · Blood · doi:10.1182/blood.v96.10.3310 · Cited by 117 · see citing works

Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia

Muramatsu, H., Makishima, H., Jankowska, A. M., Cazzolli, H., O’Keefe, C. L., Yoshida, N., Xu, Y., Nishio, N., Hama, A., Yagasaki, H., et al. (2009) · Blood · doi:10.1182/blood-2009-06-226340 · Cited by 115 · see citing works

K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells

Meter, M. E. M. V., Díaz-Flores, E., Archard, J. A., Passegue, E. A., Irish, J. M., Kotecha, N., Nolan, G. P., Shannon, K., & Braun, B. S. (2006) · Blood · doi:10.1182/blood-2006-09-047530 · Cited by 113 · see citing works

Chromosome and Molecular Abnormalities in Myelodysplastic Syndromes

Fenaux, P. (2001) · International Journal of Hematology · doi:10.1007/bf02994004 · Cited by 114 · see citing works

The Nf1 Tumor Suppressor Regulates Mouse Skin Wound Healing, Fibroblast Proliferation, and Collagen Deposited by Fibroblasts

Atit, R. P., Crowe, M. J., Greenhalgh, D. G., WENSTRUP, R. J., & Ratner, N. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00609.x · Cited by 108 · see citing works

Altered Development and Cytokine Responses of Myeloid Progenitors in the Absence of Transcription Factor, Interferon Consensus Sequence Binding Protein

Scheller, M., Foerster, J., Heyworth, C. M., Waring, J. F., Löhler, J., Gilmore, G. L., Shadduck, R. K., Dexter, T. M., & Horak, I. (1999) · Blood · doi:10.1182/blood.v94.11.3764 · Cited by 111 · see citing works

Molecular, Genetic, and Cellular Pathogenesis of Neurofibromas and Surgical Implications

Gottfried, O. N., Viskochil, D. H., Fults, D. W., & Couldwell, W. T. (2005) · Neurosurgery · doi:10.1227/01.neu.0000190651.45384.8b · Cited by 106 · see citing works

TUMOR SUPPRESSOR GENE MUTATIONS IN MICE

Jacks, T. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.603 · Cited by 104 · see citing works

Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms

Fütterer, A., Campanero, M. R., Leonardo, E., Criado, L. M., Flores, J. M., Hernández‐Rivas, J. M., Miguel, J. F. S., & Martínez‐A, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24177 · Cited by 102 · see citing works

Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation

Zhang, J., Wang, J., Liu, Y., Sidik, H., Young, K. H., Lodish, H. F., & Fleming, M. D. (2008) · Blood · doi:10.1182/blood-2008-01-134262 · Cited by 102 · see citing works

Mutant N-ras Induces Myeloproliferative Disorders and Apoptosis in Bone Marrow Repopulated Mice

MacKenzie, K. L., Dolnikov, A., Millington, M., Shounan, Y., & Symonds, G. P. (1999) · Blood · doi:10.1182/blood.v93.6.2043.406k17_2043_2056 · Cited by 99 · see citing works

Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells

McCubrey, J. A., Steelman, L., Hoyle, P., Blalock, W. L., Oppenheimer, C. W., Franklin, R. A., Cherwinski, H. M., Bosch, E., & McMahon, M. (1998) · Leukemia · doi:10.1038/sj.leu.2401215 · Cited by 98 · see citing works

Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes

Dasgupta, B., Li, W., Perry, A., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.236.65.1 · Cited by 98 · see citing works

Inherited predispositions and hyperactive Ras in myeloid leukemogenesis

Lauchle, J. O., Braun, B. S., Loh, M. L., & Shannon, K. (2006) · Pediatric Blood &amp; Cancer · doi:10.1002/pbc.20644 · Cited by 94 · see citing works

The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors

Oppenheimer, C. W., Blalock, W. L., Steelman, L. S., Chang, F., & McCubrey, J. A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00085-1 · Cited by 93 · see citing works

Acute leukemia: A pediatric perspective

Downing, J. R., & Shannon, K. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00211-8 · Cited by 92 · see citing works

Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells

Wu, X. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl208 · Cited by 93 · see citing works

Update on familial cancer syndromes and the skin

Tsao, H. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104681 · Cited by 90 · see citing works

Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.

Maris, J. M., Wiersma, S. R., Mahgoub, N., Thompson, P., Geyer, R. J., Hurwitz, C. G., Lange, B. J., & Shannon, K. (1997) · PubMed · Cited by 89 · see citing works

Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.

Li, H., Velasco-Miguel, S., Vass, W. C., Parada, L. F., & DeClue, J. E. (2002) · PubMed · Cited by 87 · see citing works

Correlation of Clinical Features With the Mutational Status of GM-CSF Signaling Pathway-Related Genes in Juvenile Myelomonocytic Leukemia

Yoshida, N., Yagasaki, H., Xu, Y., Matsuda, K., Yoshimi, A., Takahashi, Y., Hama, A., Nishio, N., Muramatsu, H., Watanabe, N., et al. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181961d2a · Cited by 84 · see citing works

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

Coons, S. W., Johnson, P. C., Scheithauer, B. W., Yates, A. J., & Pearl, D. K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7 · Cited by 559 · see citing works

Myeloid cells

Kawamoto, H., & Minato, N. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.01.020 · Cited by 81 · see citing works

Function and Signal Transduction Mediated by the Interleukin 3 Receptor System in Hematopoiesis

Hara, T., & Miyajima, A. (1996) · Stem Cells · doi:10.1002/stem.140605 · Cited by 81 · see citing works

Myelodysplasia and myeloproliferative disorders in childhood: an update

Emanuel, P. D. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.14354210.x · Cited by 81 · see citing works

A Novel Cytokine Pathway Suppresses Glial Cell Melanogenesis after Injury to Adult Nerve

Rizvi, T. A., Huang, Y., Sidani, A., Atit, R. P., Largaespada, D. A., Boissy, R. E., & Ratner, N. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09831.2002 · Cited by 80 · see citing works

Nonredundant Functions for Ras GTPase-Activating Proteins in Tissue Homeostasis

King, P. D., Lubeck, B. A., & Lapinski, P. E. (2013) · Science Signaling · doi:10.1126/scisignal.2003669 · Cited by 80 · see citing works

In Vitro and In Vivo Effects of a Farnesyltransferase Inhibitor onNf1-Deficient Hematopoietic Cells

Mahgoub, N., Taylor, B. R., Gratiot, M., Kohl, N. E., Gibbs, W. W., Jacks, T., & Shannon, K. (1999) · Blood · doi:10.1182/blood.v94.7.2469.419a01_2469_2476 · Cited by 80 · see citing works

Neurofibromin, a Tumor Suppressor in the Nervous System

Zhu, Y., & Parada, L. F. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5138 · Cited by 79 · see citing works

Aberrant Ras Regulation and Reduced p190 Tyrosine Phosphorylation in Cells Lacking p120-Gap

van der Geer, P., Henkemeyer, M. J., Jacks, Y., & Pawson, T. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.1840 · Cited by 79 · see citing works

Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders

Miles, D., Freedman, M. H., Stephens, K. G., Pallavicini, M. G., Sievers, E. L., Weaver, M., Grunberger, T., Thompson, P., & Shannon, K. (1996) · Blood · doi:10.1182/blood.v88.11.4314.bloodjournal88114314 · Cited by 79 · see citing works

Animal models of acute myelogenous leukaemia – development, application and future perspectives

McCormack, E., Bruserud, Ø., & Gjertsen, B. T. (2005) · Leukemia · doi:10.1038/sj.leu.2403670 · Cited by 75 · see citing works

NF1 Inactivation in Adult Acute Myelogenous Leukemia

Parkin, B. L., Ouillette, P. D., Wang, Y., Liu, Y., Wright, W., Roulston, D., Purkayastha, A. A., Dressel, A., Karp, J. E., Bockenstedt, P. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2639 · Cited by 75 · see citing works

Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy

Emanuel, P. D., Shannon, K., & Castleberry, R. P. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)10044-7 · Cited by 75 · see citing works

Mouse Models of Neurofibromatosis 1 and 2

Gutmann, D. H., & Giovannini, M. (2002) · Neoplasia · doi:10.1038/sj.neo.7900249 · Cited by 72 · see citing works

Nucleophosmin Mediates Mammalian Target of Rapamycin–Dependent Actin Cytoskeleton Dynamics and Proliferation in Neurofibromin-Deficient Astrocytes

Sandsmark, D. K., Zhang, H., Hegedűs, B., Pelletier, C. L., Weber, J. D., & Gutmann, D. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4470 · Cited by 70 · see citing works

Modulation of the immune response and tumor growth by activated Ras

Weijzen, S., Velders, M. P., & Kast, W. M. (1999) · Leukemia · doi:10.1038/sj.leu.2401367 · Cited by 67 · see citing works

Aberrant Growth and Differentiation of Oligodendrocyte Progenitors in Neurofibromatosis Type 1 Mutants

Bennett, M., Rizvi, T. A., Karyala, S. V., Mckinnon, R., & Ratner, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07207.2003 · Cited by 72 · see citing works

Activation of the Rap1 Guanine Nucleotide Exchange Gene,CalDAG-GEF I, in BXH-2 Murine Myeloid Leukemia

Dupuy, A. J., Morgan, K. J., von Lintig, F. C., Shen, H., Acar, H., Hasz, D. E., Jenkins, N. A., Copeland, N. G., Boss, G. R., & Largaespada, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008970200 · Cited by 66 · see citing works

Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes

Gutmann, D. H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3009 · Cited by 65 · see citing works

Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors

Emanuel, P. D., Snyder, R. C., Wiley, T. R., Gopurala, B., & Castleberry, R. P. (2000) · Blood · doi:10.1182/blood.v95.2.639 · Cited by 65 · see citing works

Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells

Donovan, S., See, W. L., Bonifas, J. M., Stokoe, D., & Shannon, K. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00214-3 · Cited by 62 · see citing works

La neurofibromatose 1 (NF1) ou maladie de Von Recklinghausen

Pinson, S., & Wolkenstein, P. (2004) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2004.06.011 · Cited by 64 · see citing works

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

Bollag, G. E., Clapp, D. W., Shih, S., Adler, F., Zhang, Y. Y., Thompson, P., Lange, B. J., Freedman, M. H., McCormick, F. P., Jacks, T., et al. (1996) · Nature Genetics · doi:10.1038/ng0296-144 · Cited by 587 · see citing works

Nf1 and Gmcsf Interact in Myeloid Leukemogenesis

Birnbaum, R. A., O'Marcaigh, A. S., Wardak, Z., Zhang, Y., Dranoff, G., Jacks, T., Clapp, D. W., & Shannon, K. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80415-3 · Cited by 138 · see citing works

Genetic Disruption of Rac1 but Not Rac2 Is Sufficient To Ameliorate the Development of Juvenile Myeloproliferative Myeloid Leukemia in Nf1−/− Mice.

Yang, F., Allen, J. D., Shi, C., Li, Y., Yuan, J., Bessler, W., Ingram, D. A., & Clapp, D. W. (2006) · Blood · doi:10.1182/blood.v108.11.3612.3612

Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines

Jacks, T., & Shannon, K. (2013)

Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice

Cutts, B. A., Sjogren, A.-K. M., Andersson, K., Wahlstrom, A. M., Karlsson, C., Swolin, B., & Bergö, M. O. (2009) · Blood · doi:10.1182/blood-2009-02-205146 · Cited by 26 · see citing works